Isoniazid is one of the most significant first-line drugs for the treatment of dynamic tuberculosis (TB) with high bactericidal movement and a decent safety profile. The rise of TB strains impervious to isoniazid takes steps to lessen the viability of TB treatment. Tuberculosis is a significant medical issue and stays one of the primary drivers of mortality. As of late, there has been an expanded enthusiasm for the aspiratory conveyance of anti-infection agents to treat tuberculosis. Isoniazid is one of these anti-infection agents.
The global Isoniazid market is segregated on the basis of Product as ≥87% Isoniazid and <87% Isoniazid. Based on End User the global Isoniazid market is segmented in Clinic, Hospital, and Other.
The global Isoniazid market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Isoniazid market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
AMSAL CHEM, Resonance Specialties, Calyx Pharma & Chem, Camus pharma, Titan Pharma (India), Taizhou Tianrui Pharmaceutical, Zhejiang Second Pharma, and others are among the major players in the global Isoniazid market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Isoniazid Market has been segmented as below:
Isoniazid Market, By Product
Isoniazid Market, By End User
Isoniazid Market, By Region
Isoniazid Market, By Company
The report covers:
Report Scope:
The global Isoniazid market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Isoniazid market share. Major industry players with significant revenue share include AMSAL CHEM, Resonance Specialties, Calyx Pharma & Chem, Camus pharma, Titan Pharma (India), Taizhou Tianrui Pharmaceutical, Zhejiang Second Pharma, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Veterinary/Animal Vaccines Market
women’s health therapeutics market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Isoniazid Market, By Product
5.1 Introduction
5.2 ≥87% Isoniazid
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 <87% Isoniazid
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Isoniazid Market, By End User
6.1 Introduction
6.2 Clinic
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Hospital
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Other
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. Isoniazid Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Isoniazid, By Product
7.2.2 North America Isoniazid, By End User
7.3 Europe
7.3.1 Europe Isoniazid, By Product
7.3.2 Europe Isoniazid, By End User
7.4 Asia-Pacific
7.4.1 Asia-Pacific Isoniazid, By Product
7.4.2 Asia-Pacific Isoniazid, By End User
7.5 Rest of the World
7.5.1 Rest of the World Isoniazid, By Product
7.5.2 Rest of the World Isoniazid, By End User
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 AMSAL CHEM
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Resonance Specialties
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Calyx Pharma & Chem
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Camus pharma
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Titan Pharma (India)
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Taizhou Tianrui Pharmaceutical
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Zhejiang Second Pharma
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
The Isoniazid Market has been segmented as below:
Isoniazid Market, By Product
Isoniazid Market, By End User
Isoniazid Market, By Region
Isoniazid Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
